Literature DB >> 15155641

Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.

Dea Garcia-Hermoso1, Françoise Dromer, Guilhem Janbon.   

Abstract

Cryptococcus neoformans capsule structure modifications after prolonged in vitro growth or in vivo passaging have been reported previously. However, nothing is known about the dynamics of these modifications or about their environmental specificities. In this study, capsule structure modifications after mouse passaging and prolonged in vitro culturing were analyzed by flow cytometry using the glucuronoxylomannan-specific monoclonal antibody E1. The capsule structures of strains recovered after 0, 1, 8, and 35 days were compared by using the level of E1-specific epitope expression and its cell-to-cell heterogeneity within a given cell population. In vitro, according to these parameters, the diversity of the strains was higher on day 35 than it was initially, suggesting the absence of selection during in vitro culturing. In contrast, the diversity of the strains recovered from the brain tended to decrease over time, suggesting that selection of more adapted strains had occurred. The strains recovered on day 35 from the spleen and the lungs had different phenotypes than the strains isolated from the brain of the same mouse on the same day, thus strongly suggesting that there is organ specificity for C. neoformans strain selection. Fingerprinting of the strains recovered in vitro and in vivo over time confirmed that genotypes evolved very differently in vitro and in vivo, depending on the environment. Overall, our results suggest that organ-specific selection can occur during cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155641      PMCID: PMC415706          DOI: 10.1128/IAI.72.6.3359-3365.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Rapid method to extract DNA from Cryptococcus neoformans.

Authors:  A Varma; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

3.  Isolation of telomerelike sequences from Cryptococcus neoformans and their use in high-efficiency transformation.

Authors:  J C Edman
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

4.  Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.

Authors:  Thomas R Kozel; Stuart M Levitz; Françoise Dromer; Marcellene A Gates; Peter Thorkildson; Guilhem Janbon
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 5.  Genetics of Cryptococcus neoformans.

Authors:  Christina M Hull; Joseph Heitman
Journal:  Annu Rev Genet       Date:  2002-06-11       Impact factor: 16.830

6.  Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response.

Authors:  Donatella Pietrella; Bettina Fries; Patrizia Lupo; Francesco Bistoni; Arturo Casadevall; Anna Vecchiarelli
Journal:  Cell Microbiol       Date:  2003-08       Impact factor: 3.715

7.  Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans.

Authors:  Frédérique Moyrand; Birgit Klaproth; Uwe Himmelreich; Françoise Dromer; Guilhem Janbon
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

8.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans.

Authors:  E D Spitzer; S G Spitzer
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

10.  Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.

Authors:  J M Small; T G Mitchell
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

View more
  45 in total

Review 1.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

2.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

3.  Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis.

Authors:  Li Li; Oscar Zaragoza; Arturo Casadevall; Bettina C Fries
Journal:  Cell Microbiol       Date:  2006-06-07       Impact factor: 3.715

4.  Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Authors:  Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.

Authors:  Bettina C Fries; Emily Cook; Xiabo Wang; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-12-21

7.  Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

Authors:  A Pool; L Lowder; Y Wu; K Forrester; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-06-04       Impact factor: 2.643

8.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

9.  Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans.

Authors:  Tiffany Guess; Hoyin Lai; Serenah E Smith; Linda Sircy; Kirsten Cunningham; David E Nelson; Erin E McClelland
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

10.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.